Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

This Week in Oncology with Punit Dhillion

  • Broadcast in Health
  • 0 comments
JustOncology

JustOncology

×  

Follow This Show

If you liked this show, you should follow JustOncology.

Call in to speak with the host

h:210699
s:3088427
archived

On the Wednesday, April 18th, 2012 broadcast, at 1:30PM Pacific and 4:30Eastern time, our special guest is Punit Dhillion, co-founder, President and Chief Executive Officer of OncoSec Medical Incorporated.

 

OncoSec Medical Inc (OTC BB: ONCS) is developing novel, localized anti-cancer therapies against solid tumors to overcome the significant cosmetic, functional and other side effects associated with surgery and other non-targeted therapeutic approaches.
 
Oncosec’s minimally invasive therapies use electrical stimulation known as electroporation to significantly increase the entry of anti-cancer chemotherapeutic or biologic agents into cells of selectively targeted tumors and tissue. These treatments selectively destroy cancer cells while preserving healthy tissue. They optimize required dosage and potentially reduce treatment and post-treatment costs. 
 
OncoSec is advancing its novel anti-cancer therapies into advanced stage clinical trials.

For more information click here.

Please join us for an exciting exploration of the promising world of cancer research.

Comments

 comments